| Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach AAT Naqvi, K Fatima, T Mohammad, U Fatima, IK Singh, A Singh, SM Atif, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (10), 165878, 2020 | 1349 | 2020 |
| Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships AAT Naqvi, T Mohammad, GM Hasan, MI Hassan Current topics in medicinal chemistry 18 (20), 1755-1768, 2018 | 308 | 2018 |
| InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening T Mohammad, Y Mathur, MI Hassan Briefings in Bioinformatics 22 (4), bbaa279, 2021 | 231 | 2021 |
| Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy A Shamsi, T Mohammad, S Anwar, MF AlAjmi, A Hussain, MT Rehman, ... Bioscience reports 40 (6), BSR20201256, 2020 | 184 | 2020 |
| Biomedical features and therapeutic potential of rosmarinic acid S Noor, T Mohammad, MA Rub, A Raza, N Azum, DK Yadav, MI Hassan, ... Archives of Pharmacal Research 45 (4), 205-228, 2022 | 151 | 2022 |
| Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4) T Mohammad, FI Khan, KA Lobb, A Islam, F Ahmad, MI Hassan Journal of Biomolecular Structure and Dynamics 37 (7), 1813-1829, 2019 | 134 | 2019 |
| Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and … T Mohammad, S Siddiqui, A Shamsi, MF Alajmi, A Hussain, A Islam, ... Molecules 25 (4), 823, 2020 | 129 | 2020 |
| FNDC5/irisin: physiology and pathophysiology R Waseem, A Shamsi, T Mohammad, MI Hassan, SN Kazim, ... Molecules 27 (3), 1118, 2022 | 126 | 2022 |
| Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression F Naz, FI Khan, T Mohammad, P Khan, S Manzoor, GM Hasan, KA Lobb, ... International journal of biological macromolecules 107, 2580-2589, 2018 | 118 | 2018 |
| Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy S Anwar, A Shamsi, T Mohammad, A Islam, MI Hassan Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (1), 188568, 2021 | 111 | 2021 |
| Potential drug targets of SARS-CoV-2: From genomics to therapeutics A Shamsi, T Mohammad, S Anwar, S Amani, MS Khan, FM Husain, ... International Journal of Biological Macromolecules 177, 1-9, 2021 | 109 | 2021 |
| Identification and Evaluation of Inhibitors of Lipase from Malassezia restricta using Virtual High-Throughput Screening and Molecular Dynamics Studies S Ali, FI Khan, T Mohammad, D Lan, MI Hassan, Y Wang International journal of molecular sciences 20 (4), 884, 2019 | 108 | 2019 |
| MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer’s disease therapy A Shamsi, S Anwar, T Mohammad, MF Alajmi, A Hussain, MT Rehman, ... Biomolecules 10 (5), 789, 2020 | 103 | 2020 |
| Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy R Dahiya, T Mohammad, S Roy, S Anwar, P Gupta, A Haque, P Khan, ... International journal of biological macromolecules 136, 1076-1085, 2019 | 99 | 2019 |
| Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy T Mohammad, A Shamsi, S Anwar, M Umair, A Hussain, MT Rehman, ... Virus research 288, 198102, 2020 | 98 | 2020 |
| Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy P Gupta, T Mohammad, P Khan, MF Alajmi, A Hussain, MT Rehman, ... Biomedicine & Pharmacotherapy 118, 109245, 2019 | 90 | 2019 |
| Discovery of Hordenine as a potential inhibitor of pyruvate dehydrogenase kinase 3: implication in lung Cancer therapy S Anwar, T Mohammad, A Shamsi, A Queen, S Parveen, S Luqman, ... Biomedicines 8 (5), 119, 2020 | 89 | 2020 |
| B cell lymphoma 2: a potential therapeutic target for cancer therapy M Alam, S Ali, T Mohammad, GM Hasan, DK Yadav, MI Hassan International journal of molecular sciences 22 (19), 10442, 2021 | 74 | 2021 |
| Identification of α-mangostin as a potential inhibitor of microtubule affinity regulating kinase 4 P Khan, A Queen, T Mohammad, Smita, NS Khan, ZB Hafeez, MI Hassan, ... Journal of natural products 82 (8), 2252-2261, 2019 | 71 | 2019 |
| Genomic variations in the structural proteins of SARS-CoV-2 and their deleterious impact on pathogenesis: a comparative genomics approach T Mohammad, A Choudhury, I Habib, P Asrani, Y Mathur, M Umair, ... Frontiers in cellular and infection microbiology 11, 765039, 2021 | 69 | 2021 |
Imtaiyaz HassanJamia Millia IslamiaVerified email at jmi.ac.in
